97157 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons; Tumor Necrosis Factors Lymphotoxin [LT]
PROCESS FOR MANIPULATING THE LEVEL OF GLYCAN CONTENT OF A GLYCOPROTEIN
#2T CELL AND ANTIGEN-PRESENTING CELL ENGAGERS AND USES THEREOF
#3PROCESS FOR MANIPULATING THE LEVEL OF GLYCAN CONTENT OF A GLYCOPROTEIN
#4MODIFIED ANTIBODIES CONTAINING MODIFIED IGG2 DOMAINS WHICH ELICIT AGONIST OR ANTAGONISTIC PROPERTIES AND USE THEREOF
#5PROCESS FOR MANIPULATING THE LEVEL OF GLYCAN CONTENT OF A GLYCOPROTEIN
#6Process for manipulating the level of glycan content of a glycoprotein
#7PROCESS FOR MANIPULATING THE LEVEL OF GLYCAN CONTENT OF A GLYCOPROTEIN
#8Process for manipulating the level of glycan content of a glycoprotein
#9Modified antibodies containing modified IGG2 domains which elicit agonist or antagonistic properties and use thereof
#10METHODS OF TREATING OBESITY
#11Antibodies to lymphotoxin-alpha
#12Therapeutic using a bispecific antibody
#13ANTI-LYMPHOTOXIN ANTIBODIES
#14BLOCKERS OF LIGHT, LTalpha1beta2 AND LTalpha2beta1 OR ITS RECEPTOR LTbetaR FOR THE PREVENTION AND TREATMENT OF CHRONIC HEPATITIS AND OTHER LIVER DISEASES
#15Antibodies to lymphotoxin-α
#16Antibodies to lymphotoxin-α
#17Method for restoring dendritic cell populations
#18Antibodies to lymphotoxin-alpha
#19REVERSAL OF VIRAL-INDUCED SYSTEMIC SHOCK AND RESPIRATORY DISTRESS BY BLOCKADE OF THE LYMPHOTOXIN BETA PATHWAY
#20Protein (poly)peptides libraries
#21Therapeutic using a bispecific antibody
#22Lymphotoxin-beta, lymphotoxin-beta Complexes, pharmaceutical preparations and therapeutic uses thereof
#23Treatment of immunological renal disorders by lymphotoxin pathway inhibitors
#24Protein (poly)peptides libraries
#25Anti-human lymphotoxin alpha antibodies, compositions, methods and uses